Benjamin E. Lee
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- COVID-19 and healthcare impacts 1
- Co-authors
- Nasser Khaled Altorki (9 shared papers)Brendon Matthew Stiles (4 shared papers)Jeffrey L. Port (6 shared papers)Ashish Saxena (3 shared papers)Ronald J Scheff (2 shared papers)Peter J. Kneuertz (3 shared papers)Bradley B. Pua (1 shared paper)Silvia Chiara Formenti (2 shared papers)
- Journals
- The Annals of Thoracic Surgery (3 papers)Journal of Thoracic and Cardiovascular Surgery (2 papers)The Lancet Oncology (1 paper)Nature Communications (1 paper)Clinical Lung Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Benjamin E. Lee
11 papers receiving 540 citations
Benjamin E. Lee's Hit Papers
Peers
Comparison fields: 5 of 46
- Oncology 212
- Pulmonary and Respiratory Medicine 190
- Health Informatics 10
- Neurology 53
- Immunology 43
Countries citing papers authored by Benjamin E. Lee
This map shows the geographic impact of Benjamin E. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin E. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin E. Lee more than expected).
Fields of papers citing papers by Benjamin E. Lee
This network shows the impact of papers produced by Benjamin E. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin E. Lee. The network helps show where Benjamin E. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin E. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial Hit paper breakdown → | 2021 | 274 |
| 2 | 1992 | 58 | |
| 3 | 2017 | 55 | |
| 4 | 2018 | 46 | |
| 5 | 2009 | 40 | |
| 6 | 2023 | 38 | |
| 7 | 2021 | 18 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2024 | 4 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 0 |
About Benjamin E. Lee
Benjamin E. Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Health Informatics and Epidemiology, having authored 12 papers that have together received 552 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Myasthenia Gravis and Thymoma (2 papers), Artificial Intelligence in Healthcare and Education (1 paper), COVID-19 and healthcare impacts (1 paper), Multiple and Secondary Primary Cancers (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Oncology (212 citations), Pulmonary and Respiratory Medicine (190 citations), Health Informatics (10 citations), Neurology (53 citations) and Immunology (43 citations). Benjamin E. Lee has collaborated with scholars based in United States. Frequent co-authors include Nasser Khaled Altorki, Brendon Matthew Stiles, Jeffrey L. Port, Ashish Saxena, Ronald J Scheff, Peter J. Kneuertz, Bradley B. Pua, Silvia Chiara Formenti, Manik Uppal and Olivier Elemento. Their work appears in journals such as The Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, The Lancet Oncology, Nature Communications and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.